Sinopharm Tech Holdings Limited expects to record a profit attributable to equity holders of the Company of not less than HKD 15.0 million for the six months ended 31 December 2022, as compared with a loss attributable to equity holders of the Company of approximately HKD 13.5 million for the corresponding period in 2021.
Sinopharm Tech Holdings Limited
Equities
8156
KYG2159V1418
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.116 HKD | +13.73% | +22.11% | -12.12% |
Feb. 29 | Sinopharm Tech Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 | CI |
2023 | Sinopharm Tech Holdings Limited Announces Management Changes | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.12% | 2.72M | |
-3.43% | 184B | |
-1.81% | 107B | |
-4.15% | 67.78B | |
+1.43% | 50.66B | |
+11.60% | 47.64B | |
+4.60% | 41.12B | |
+3.03% | 26.3B | |
+3.21% | 26.04B | |
+15.06% | 25.4B |
- Stock Market
- Equities
- 8156 Stock
- News Sinopharm Tech Holdings Limited
- Sinopharm Tech Holdings Provides Earnings Guidance for the Six Months Ended December 31, 2022